stockrowMediciNova, Inc. (MNOV) vs Neuraxis, Inc. (NRXS)
- MediciNova, Inc. MNOV 1.46 +0.69%
- Neuraxis, Inc. NRXS 6.31 +3.27%
MediciNova, Inc. and Neuraxis, Inc. are both Biotechnology companies. MediciNova, Inc. and Neuraxis, Inc. are of similar size ($76.7M and $71.4M). Neuraxis, Inc. grew revenue faster over the last twelve months: 65.2% against −82.2%. Neuraxis, Inc. has the higher net margin (−159.0% vs −1,168.3%) and the higher return on invested capital (0.00% vs −62.5%). Across the 16 metrics below, Neuraxis, Inc. leads on 12 and MediciNova, Inc. on 4.
Valuation
Profitability
| Metric | MNOV | NRXS | Biotechnology median |
|---|---|---|---|
| Gross margin | 37.76% | 85.56% | 68.51% |
| Operating margin | (1,287.53%) | (144.51%) | 0.00% |
| Net margin | (1,168.31%) | (159.01%) | 0.00% |
| Free cash flow margin | (991.31%) | (106.10%) | 0.00% |
| Return on equity | (25.56%) | (153.96%) | (51.96%) |
| Return on assets | (23.83%) | (98.96%) | (46.06%) |
| Return on invested capital | (62.48%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack